The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.
A federal docket on the therapeutic use of psychedelics is open through October 5. Four groups that built this movement from the ground up on what they’d tell the government, what they’re fighting in court, and how much of their work the docket doesn’t cover. The Food and Drug Administration held a public hearing on […]
Addressing Cannabis Safety Issues Is A Strength, Not A Weakness, For The Legalization Movement (Op-Ed)
“Acknowledging these problems is not a concession to prohibition. Solving them is how we protect the future of cannabis access.” By Steph Sherer, Americans for Safe Access For much of the modern cannabis movement, raising concerns about safety has been politically complicated. Advocates have spent decades fighting exaggerated claims about cannabis harms, and opponents have […]


